Terms: = Uterine cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Prognosis
28 results:
1. Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma.
Yokoi A; Nakamura Y; Hashimura M; Oguri Y; Matsumoto T; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Saegusa M
BMC Cancer; 2023 Aug; 23(1):765. PubMed ID: 37592266
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
3. Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors.
Dufresne A; Pissaloux D; Ngo C; Penel N; Le Cesne A; Macagno N; Vanacker H; Hénon C; Jean-Denis M; Rughoo K; Tirode F; Blay JY; Brahmi M
ESMO Open; 2023 Apr; 8(2):101202. PubMed ID: 37054503
[TBL] [Abstract] [Full Text] [Related]
4. uterine inflammatory myofibroblastic tumor.
Karpathiou G; Devouassoux-Shisheboran M; Stolnicu S; Chauleur C; Péoc'h M
Pathol Res Pract; 2023 Feb; 242():154335. PubMed ID: 36706588
[TBL] [Abstract] [Full Text] [Related]
5. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
6. Prognostic value of lymph node ratio in cervical cancer: A meta-analysis.
Cui H; Huang Y; Wen W; Li X; Xu D; Liu L
Medicine (Baltimore); 2022 Oct; 101(42):e30745. PubMed ID: 36281189
[TBL] [Abstract] [Full Text] [Related]
7. Epidemiological Trends and Attributable Risk Burden of Cervical cancer: An Observational Study from 1990 to 2019.
Yao H; Yan C; Qiumin H; Li Z; Jiao A; Xin L; Hong L
Int J Clin Pract; 2022; 2022():3356431. PubMed ID: 36263235
[TBL] [Abstract] [Full Text] [Related]
8. The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.
He Z; Chen R; Hu S; Zhang Y; Liu Y; Li C; Lv F; Xiao Z
BMC Cancer; 2022 Jul; 22(1):776. PubMed ID: 35840910
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
10. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
[TBL] [Abstract] [Full Text] [Related]
11. [Relationship between serum folate and CIN1 prognosis and its interaction with HR-HPV infection].
Qi Z; Ding L; Meng D; Liu H; Wang J; Song L; Lyu YJ; Jia HX; Hao M; Tian ZQ; Wang JT
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):866-871. PubMed ID: 34407593
[No Abstract] [Full Text] [Related]
12. A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer.
Maulard A; Chargari C; Faron M; Alwohaibi A; Leary A; Pautier P; Genestie C; Morice P; Gouy S
Gynecol Oncol; 2020 Nov; 159(2):534-538. PubMed ID: 32828580
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Outcomes in Early Cervical cancer Patients Treated with Nerve Plane-sparing Laparoscopic Radical Hysterectomy.
Zhao D; Li B; Wang Y; Liu S; Zhang Y; Yuan G
J Minim Invasive Gynecol; 2020; 27(3):687-696. PubMed ID: 31075445
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive analysis of PD-L1 expression, HER2 amplification, alk/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.
Schmoeckel E; Hofmann S; Fromberger D; Rottmann M; Luthardt B; Burges A; Jeschke U; Kirchner T; Lax SF; Mayr D
Virchows Arch; 2019 May; 474(5):599-608. PubMed ID: 30734108
[TBL] [Abstract] [Full Text] [Related]
15. [Study of conizations of the cervix after five years of cervical cancer screening with co-testing].
Oncins Torres R; Aragón Sanz MÁ; Clemente Roldán E; Comes García MD; Muñiz Unamunzaga G; Guardia Dodorico L; Vallés Gallego V
Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30270344
[TBL] [Abstract] [Full Text] [Related]
16. Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial cancer?
Ghanem AI; Modh A; Burmeister C; Munkarah AR; Elshaikh MA
Gynecol Obstet Invest; 2018; 83(3):290-298. PubMed ID: 29518778
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer.
Boromand N; Hasanzadeh M; ShahidSales S; Farazestanian M; Gharib M; Fiuji H; Behboodi N; Ghobadi N; Hassanian SM; Ferns GA; Avan A
J Cell Physiol; 2018 Jun; 233(6):4490-4496. PubMed ID: 29058790
[TBL] [Abstract] [Full Text] [Related]
18. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
Busca A; Parra-Herran C
Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
[TBL] [Abstract] [Full Text] [Related]
19. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.
Bennett JA; Nardi V; Rouzbahman M; Morales-Oyarvide V; Nielsen GP; Oliva E
Mod Pathol; 2017 Oct; 30(10):1489-1503. PubMed ID: 28664932
[TBL] [Abstract] [Full Text] [Related]
20. Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis.
Cheng KY; Wang ZL; Gu QY; Hao M
PLoS One; 2016; 11(10):e0165117. PubMed ID: 27764228
[TBL] [Abstract] [Full Text] [Related]
[Next]
